iSelect Fund
  • Portfolio
  • Team
  • Focus Areas
    • Food & Agriculture
    • Healthcare
    • Food is Health
    • Soil Health
    • Impact Investing
    • Entrepreneurs
  • Invest
  • Insights
  • Contact
  • My iSelect
    • My iSelect Login
Select Page
The End of Trial-and-Error Psychiatry

The End of Trial-and-Error Psychiatry

Americans spent more than $140 billion on behavioral health and substance use treatments last year, up from $40.9 billion in 2000. That’s a 3.4x increase in 25 years, against a backdrop of mental health outcomes that have not improved. Half of all Americans will... Read more

MICROBIOME PLATFORM COMPANY HOLOBIOME ANNOUNCES COLLABORATION TO DEVELOP PRODUCTS FOR INFANT AND MATERNAL HEALTH

Read more

Unilever initiative targets gut/brain link

Read more

Microbiome company Finch Therapeutics begins trading publicly, quietly shuffles one of its executives

Read more

Gut Bacteria’s Role in Anxiety and Depression: It’s Not Just In Your Head

Read more

Stomach “Psychobiome” Capable of Influencing Thoughts

Read more
« Older Entries

Related Posts

  • Agrible AB-InBev Partnership
    AB InBev iSelect portfolio company Agrible partner on Barley
  • invest in energy
    iSelect Adds New Portfolio Company: Bractlet
  • The 25 Most Innovative AgTech Startups In 2018
  • iSelect Fund
    What Is the Appeal of iSelect to Investors?
  • invest outside Silicon Valley
    The Role of Diversification in Venture Investing
AgTechFund BLOG SIDEBAR

(314) 219-8688

7750 Maryland Ave
Box 11826
St. Louis, MO 63105

Crunchbase   Twitter   LinkedIn   Facebook   YouTube

Securities offered through North Capital Private Securities ("NCPS"), Member FINRA/SIPC, located at 623 East Ft. Union Blvd, Suite 101, Salt Lake City, UT 84047. NCPS does not make investment recommendations and no communication, through this website or in any other medium should be construed as a recommendation for any security offered on or off this investment platform.  Please review North Capital’s Form CRS and its background on FINRA’s BrokerCheck.  Investments in private offerings are speculative, illiquid and involve a high degree of risk and those investors who cannot afford to lose their entire investment and who cannot hold an investment for an indeterminate period should not invest in such offerings. Past performance is not indicative of future results.  All information provided herein should not be relied upon to make an investment decision and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Prospective investors are recommended to consult with a financial adviser, attorney, accountant, and any other professional that can help you understand and assess the risks associated with an investment opportunity. Investments in startups are highly illiquid and those investors who cannot hold an investment for the long term (at least 5-7 years) should not invest.